• 1. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 2. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 3. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267
• 4. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 5. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938

Introduction to 5-(pyridin-3-yl)-1H-pyrazole-3-carboxylic acid (CAS No. 374064-01-4)

5-(pyridin-3-yl)-1H-pyrazole-3-carboxylic acid, identified by the chemical identifier CAS No. 374064-01-4, is a significant compound in the realm of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic compound features a fused ring system consisting of a pyrazole core and a pyridine substituent, making it a versatile scaffold for drug discovery and medicinal chemistry applications. The structural motif of 5-(pyridin-3-yl)-1H-pyrazole-3-carboxylic acid has garnered considerable attention due to its potential biological activities and its role as a key intermediate in the synthesis of more complex molecules.

The pyrazole ring is a nitrogen-containing heterocycle that is widely recognized for its presence in numerous biologically active compounds, including antifungals, antivirals, and anticancer agents. The introduction of a pyridin-3-yl group at the 5-position of the pyrazole ring introduces additional electronic and steric properties that can modulate the biological activity of the molecule. This substitution pattern is particularly interesting because it allows for further functionalization at both the pyridine and pyrazole moieties, providing chemists with a rich palette of possibilities for designing novel therapeutic agents.

In recent years, there has been growing interest in the development of small-molecule inhibitors targeting various enzyme families involved in critical biological pathways. The 5-(pyridin-3-yl)-1H-pyrazole-3-carboxylic acid scaffold has been explored as a potential inhibitor in several contexts, particularly in the inhibition of protein kinases, which are known to be aberrantly activated in many diseases, including cancer. The pyridine moiety can serve as a hydrogen bond acceptor or donor, facilitating interactions with specific residues in the target enzyme's active site. Additionally, the carboxylic acid group at the 3-position of the pyrazole ring can be further functionalized to enhance binding affinity or to introduce additional pharmacological properties.

One of the most compelling aspects of 5-(pyridin-3-yl)-1H-pyrazole-3-carboxylic acid is its utility as a building block in medicinal chemistry. Researchers have leveraged this compound to synthesize derivatives with enhanced potency, selectivity, and pharmacokinetic profiles. For instance, studies have demonstrated that replacing the carboxylic acid group with various amides or esters can significantly improve solubility and metabolic stability, making these derivatives more suitable for clinical development. Furthermore, incorporating additional substituents into the pyridine ring can fine-tune electronic properties, thereby modulating reactivity and bioavailability.

The synthesis of 5-(pyridin-3-yl)-1H-pyrazole-3-carboxylic acid typically involves multi-step organic transformations starting from commercially available precursors. One common synthetic route involves the condensation of 3-bromopyridine with an appropriate hydrazine derivative followed by cyclization under acidic conditions. Alternatively, palladium-catalyzed cross-coupling reactions have been employed to introduce the pyridine moiety onto the pyrazole core with high efficiency. These synthetic strategies highlight the versatility of 5-(pyridin-3-yl)-1H-pyrazole-3-carboxylic acid as a synthetic intermediate and underscore its importance in industrial-scale pharmaceutical production.

Recent advancements in computational chemistry have further enhanced our ability to design and optimize derivatives of 5-(pyridin-3-yl)-1H-pyrazole-3-carboxylic acid. Molecular docking studies combined with quantum mechanical calculations have been used to predict binding modes and affinities for various target proteins. These computational approaches not only accelerate the discovery process but also provide valuable insights into structure-function relationships, enabling rational drug design. By leveraging these tools, researchers can rapidly screen large libraries of compounds and identify promising candidates for further experimental validation.

The biological activity of 5-(pyridin-3-yl)-1H-pyrazole-3-carboxylic acid has been extensively studied in both in vitro and in vivo systems. Preclinical investigations have revealed that this compound exhibits inhibitory effects on several enzymes implicated in disease pathways. For example, derivatives of this scaffold have shown promise as inhibitors of Janus kinases (JAKs), which are involved in inflammatory responses and have been implicated in autoimmune diseases such as rheumatoid arthritis. Additionally, studies suggest that modifications to the pyridin-3-yl group can enhance binding to specific JAK isoforms, leading to improved therapeutic selectivity.

In addition to its kinase inhibition properties, 5-(pyridin-3-yl)-1H-pyrazole-3-carboxylic acid has been explored for its potential antitumor activity. Preliminary experiments have indicated that certain derivatives exhibit cytotoxic effects against various cancer cell lines by interfering with critical signaling pathways involved in cell proliferation and survival. The ability of these compounds to induce apoptosis or arrest cell cycle progression makes them attractive candidates for further development as anticancer agents. Further research is needed to fully elucidate their mechanisms of action and assess their potential for clinical translation.

The development of novel therapeutic agents often requires careful consideration of pharmacokinetic parameters such as absorption, distribution, metabolism, excretion (ADME), and toxicity (TOX). The structural features of 5-(pyridin-3-yl)-1H-pyrazole-3-carboxylic acid influence these parameters significantly. For instance, the presence of a carboxylic acid group can affect solubility and ionization state at physiological pH levels, while substituents on the pyridine ring can influence metabolic stability through interactions with cytochrome P450 enzymes. Optimizing these properties is essential for ensuring that drug candidates reach their target sites effectively and exhibit minimal off-target effects.

The role of 5-(pyridin-3-yll)-1H-pyrazole -carb oxy lic ac id as an intermediate has also been recognized in materials science applications beyond pharmaceuticals. Its unique structural characteristics make it suitable for use in organic electronics, where it can serve as a component in conductive polymers or liquid crystal displays (LCDs). The ability to modify both rings independently allows chemists to tailor electronic properties such as charge transportability and luminescence efficiency, making this compound valuable for developing advanced materials with specialized functions.

In conclusion,5-(pyridin - 31 - yl ) - 11 H - p yra zol e - 31 - ca rbo x y l ic ac id(CAS No . 374064 -01 -4)is a multifaceted compound with significant potential across multiple disciplines . Its utility asa scaffoldfor drug discovery , synthetic intermediate ,and material science application underscores its importance . With ongoing research efforts focused on optimizing its biological activity ,pharmacokinetic profiles ,and industrial applicability,this compoundis poisedto play an increasingly important role int he future developmentof innovative therapiesand technologies . p >

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)